Connection
Fenghuang Zhan to Leukemia, Lymphocytic, Chronic, B-Cell
This is a "connection" page, showing publications Fenghuang Zhan has written about Leukemia, Lymphocytic, Chronic, B-Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.180 |
|
|
|
-
Li Z, Li F, Yi S, Gu Z, Yu Z, Xu Y, Feng X, Liu W, Zou D, Qi J, Zhan F, Qiu L. Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China. BMC Cancer. 2015 Jul 29; 15:555.
Score: 0.125
-
Zent CS, Zhan F, Schichman SA, Bumm KH, Lin P, Chen JB, Shaughnessy JD. The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype. Leuk Res. 2003 Sep; 27(9):765-74.
Score: 0.055